医学
逐渐变细
胰高血糖素样肽1受体
肥胖
胰高血糖素样肽-1
兴奋剂
受体
持续时间(音乐)
内科学
内分泌学
糖尿病
药理学
2型糖尿病
文学类
艺术
计算机图形学(图像)
计算机科学
作者
Jennifer Manne‐Goehler,Felix Teufel,François Venter
标识
DOI:10.1001/jamainternmed.2024.3579
摘要
This Viewpoint discusses the optimal treatment duration of glucagon-like peptide-1 receptor agonists in people with obesity and the benefits of off-ramping, the tapering of these antiobesity medications following an initial treatment period.
科研通智能强力驱动
Strongly Powered by AbleSci AI